Draper Asset Management, LLC Invitae Corp Transaction History

Draper Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$1.71 - $3.61 $38,180 - $80,604	-22,328 Reduced 99.62%	86 $0
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $611 - $2,778	-322 Reduced 1.42%	22,414 $55,000
Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $677 - $2,865	-318 Reduced 1.38%	22,736 $55,000
Q1 2022 May 13, 2022	SELL	$6.28 - $15.59 $2,744 - $6,812	-437 Reduced 1.86%	23,054 $184,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $73,911 - $144,152	5,028 Added 27.23%	23,491 $359,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $62,817 - $86,822	2,584 Added 16.27%	18,463 $525,000
Q2 2021 Aug 10, 2021	BUY	$26.09 - $40.4 $161,210 - $249,631	6,179 Added 63.7%	15,879 $536,000
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $44,961 - $77,424	1,360 Added 16.31%	9,700 $371,000
Q4 2020 Mar 03, 2021	BUY	$39.09 - $57.4 $326,010 - $478,716	8,340 New	8,340 $349,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Draper Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Draper Asset Management, LLC with notifications on news.